Physician profile
David J Teeple
NPI 1316132319
$4,833.46
in general payments reported to CMS, 2019-2025
9 companies · $19.03 in 2025
The $19.03 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $13.53 · 2021: $50.31 · 2023: $2,337 · 2024: $2,288 · 2025: $19.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $143.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene, LTD. | $4,500.00 | 2023-2024 | Brukinsa |
| Chiesi USA, INC. | $135.30 | 2019-2025 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $48.39 | 2019 | |
| Abbott Laboratories | $48.13 | 2023 | Mitraclip |
| Medtronic USA, INC. | $37.43 | 2019 | |
| Microtransponder, INC. | $22.11 | 2024 | |
| Lantheus Medical Imaging, INC. | $17.34 | 2019 | |
| Biogen, INC. | $13.59 | 2021 | |
| Abbvie INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Teeple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.